Clinical Trials at Rutgers New Jersey Medical School
As of August 2026, 19 paid clinical trials are recruiting at Rutgers New Jersey Medical School, located at 185 S ORANGE AVE, NEWARK, NJ 07103-2757, phone (973) 972-5714 in Newark, New Jersey. Active studies at this site cover conditions such as Heart Failure, Heart Diseases and Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
19 clinical trials at Rutgers New Jersey Medical School
·Clear filters·Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy
Liver Transplantation in Intrahepatic Cholangiocarcinoma
Effect of Superior Laryngeal Nerve Blocks on Patient Outcomes in Laryngeal Surgery
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Common conditions studied in Newark
- Heart Failure (5 active studies)
- Heart Diseases (4 active studies)
- Breast Cancer (3 active studies)
- Cardiovascular Diseases (3 active studies)
- HIV Infections (3 active studies)
- Sickle Cell Disease (3 active studies)
Leading research sponsors in Newark
- Rutgers, The State University of New Jersey
- National Cancer Institute (NCI)
- Children's Oncology Group
- NRG Oncology
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Newark?
There are approximately 118 recruiting clinical trials in Newark, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Newark pay participants?
Most recruiting trials in Newark compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Newark?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Newark?
The most common conditions under active study in Newark include Heart Failure (5), Heart Diseases (4), Breast Cancer (3), Cardiovascular Diseases (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Newark?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Newark on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Newark?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Newark?
Recruiting research sites in Newark include Newark Beth Israel Medical Center, Rutgers New Jersey Medical School, University Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Newark right now?
The largest active categories in Newark are Cancer & tumors (38), Neurology & pain (11), Cardiovascular (9). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Rutgers New Jersey Medical School?
Rutgers New Jersey Medical School is located at 185 S ORANGE AVE, NEWARK, NJ 07103-2757. Use the Google Maps link in the intro above to get directions.
How do I contact Rutgers New Jersey Medical School?
You can reach Rutgers New Jersey Medical School by phone at (973) 972-5714. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.